(R)-4-Propyldihydrofuran-2(3H)-one

(R)-4-Propyldihydrofuran-2(3H)-one is a chiral pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients (APIs) and other biologically active compounds. Its optically pure (R)-configuration makes it an important building block in asymmetric synthesis and stereoselective drug development.

This intermediate is manufactured with high enantiomeric purity and controlled impurity profiles to ensure consistency, stability, and reproducibility in downstream chemical processes. It is suitable for research and development, process optimization, and scale-up for commercial pharmaceutical manufacturing, supporting the development of therapeutics across multiple applications.